AU6460200A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- AU6460200A AU6460200A AU64602/00A AU6460200A AU6460200A AU 6460200 A AU6460200 A AU 6460200A AU 64602/00 A AU64602/00 A AU 64602/00A AU 6460200 A AU6460200 A AU 6460200A AU 6460200 A AU6460200 A AU 6460200A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902937A SE9902937D0 (en) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
SE9902937 | 1999-08-18 | ||
PCT/GB2000/003114 WO2001011933A2 (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions comprising a 7-(2-aminoethyl)-benzothiazolone and a pde4 inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6460200A true AU6460200A (en) | 2001-03-13 |
Family
ID=20416695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU64602/00A Abandoned AU6460200A (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR025341A1 (en) |
AU (1) | AU6460200A (en) |
SE (1) | SE9902937D0 (en) |
WO (1) | WO2001011933A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR029984A1 (en) * | 2000-07-27 | 2003-07-23 | Smithkline Beecham Corp | METHOD FOR REDUCING ASSOCIATED EXCERBATIONS COPD AMBITO |
CA2543858C (en) | 2003-11-21 | 2014-04-15 | Theravance, Inc. | Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
EP2255189B8 (en) * | 2008-02-07 | 2015-05-06 | Michael M. Grunstein | Compositions and methods which modulate g-protein signaling for the treatment of asthma |
US8569229B2 (en) | 2008-02-07 | 2013-10-29 | The Children's Hospital Of Philadelphia | Compositions and methods which modulate G-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis |
WO2009154557A1 (en) | 2008-06-18 | 2009-12-23 | Astrazeneca Ab | Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9211172D0 (en) * | 1992-05-27 | 1992-07-08 | Fisons Plc | Compounds |
-
1999
- 1999-08-18 SE SE9902937A patent/SE9902937D0/en unknown
-
2000
- 2000-08-14 AU AU64602/00A patent/AU6460200A/en not_active Abandoned
- 2000-08-14 WO PCT/GB2000/003114 patent/WO2001011933A2/en active Application Filing
- 2000-08-18 AR ARP000104311A patent/AR025341A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001011933A2 (en) | 2001-02-22 |
AR025341A1 (en) | 2002-11-20 |
SE9902937D0 (en) | 1999-08-18 |
WO2001011933A3 (en) | 2001-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU781269C (en) | Pharmaceutical compositions | |
AU3192700A (en) | Medicinal compositions | |
HUP0202513A2 (en) | Betha-carboline pharmaceutical compositions | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU1071301A (en) | Pharmaceutical compounds | |
GB0028088D0 (en) | Pharmaceutical compositions | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
GB0001662D0 (en) | Pharmaceutical compositions | |
AU3556400A (en) | Pharmaceutical compositions | |
AU2005300A (en) | Medicinal compositions | |
GB9923436D0 (en) | Pharmaceutical compositions | |
AU1887401A (en) | Medicinal composition | |
AU4328800A (en) | Pharmaceutical formulation | |
AU1735001A (en) | Cyclodextrin-containing pharmaceutical composition | |
AU6715600A (en) | Pharmaceutical formulations | |
GB9904163D0 (en) | Pharmaceutical compositions | |
AU4304400A (en) | Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives | |
AU6460400A (en) | Pharmaceutical compositions | |
AU5460800A (en) | Pharmaceutical transdermal compositions | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
GB9911017D0 (en) | Pharmaceutical compositions | |
AU2681500A (en) | Rapidly-soluble compositions | |
AU4977300A (en) | Pharmaceutical formulations | |
AU6460200A (en) | Pharmaceutical compositions | |
AU1385801A (en) | Pharmaceutical formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |